William M. Greenman, President, CEO & Chairman, reported "another quarter of both solid commercial and product development execution" and highlighted the growing clinical evidence for the INTERCEPT ...
Cerus Corporation’s latest earnings call struck an upbeat tone, with management emphasizing strong commercial momentum and record results despite some margin headwinds. Revenue growth, accelerating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results